Fifteen years after its first FDA approval for treating schizophrenia with Fanapt (iloperidone), Vanda Pharmaceuticals has achieved another success. Fanapt is a type of antipsychotic medication that deviates from the usual and has been administered to individuals with schizophrenia for their immediate treatment following its approval by the FDA in 2009. Despite its label stating that the precise method of operation remains unidentified, Vanda suggests that Fanapt functions by inhibiting dopamine type 2 and serotonin type 2 receptors. The FDA has approved Fanapt tablets for the treatment of manic or mixed episodes linked to bipolar I disorder in adults. This led to a 3...
